Market Overview

UPDATE: Stifel Nicolaus Raises PT to $35 on Team Health Holdings on EPS Visibility

Related TMH
Barclays Analyst Sees Sick Shifting From Hospitals To Outpatient Clinics
TeamHealth Acquires Premier Physician Services
Team Health Holdings: A Well-Run Company With Strong Growth Prospects (Seeking Alpha)

Stifel Nicolaus reiterated its Buy rating on Team Health Holdings (NYSE: TMH) and the price target from $30.00 to $35.00.

Stifel Nicolaus said, "The flu epidemic has made this the most active flu season in the U.S. since the H1N1 pandemic in the fall of 2009. Our analysis of (admittedly limited) historical data indicates a strong correlation between year-over-year changes in flu activity and Team's same-store volumes. This suggests upside to at least fourth quarter 2012 earnings. Given a favorable operating and acquisition environment, and the positive impact of Medicaid Parity on 2013 and 2014 earnings, we are raising our target price from $30 to $35."

Team Health Holdings closed at $31.89 on Friday.

Latest Ratings for TMH

Jan 2015CitigroupDowngradesBuyNeutral
Sep 2014Stifel NicolausMaintainsBuy
Sep 2014Deutsche BankMaintainsHold

View More Analyst Ratings for TMH
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Price Target Intraday Update Analyst Ratings


Related Articles (TMH)

Around the Web, We're Loving...

Get Benzinga's Newsletters